Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Applying an Open-Source Segmentation Algorithm to Different OCT Devices in Multiple Sclerosis Patients and Healthy Controls: Implications for Clinical Trials.
High risk of cardiovascular diseases after diagnosis of multiple sclerosis.
Acute transverse myelitis after thoracic epidural anesthesia and analgesia: Should anesthesia and analgesia be blamed?
Adolescents' experiences on coping with parental multiple sclerosis: a grounded theory study.
Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis.
Fingolimod Therapy and Macular Hemorrhage.
Relation of helicobacter pylori infection and multiple sclerosis in Iranian patients.
[Differential diagnosis of multiple sclerosis with pediatric onset: the experience of the Moscow Division for treatment of children and adolescents with multiple sclerosis.]
The role of the immune system in the generation of neuropathic pain.
Longitudinal interferon-β effects in multiple sclerosis: Differential regulation of IL-10 and IL-17A, while no sustained effects on IFN-γ, IL-4 or IL-13.
Role of metabotropic glutamate receptor 5 signaling and homer in oxygen glucose deprivation-mediated astrocyte apoptosis.
Multiple sclerosis: Progression rate and severity in a multicenter cohort from Algeria.
Japanese cases of neuromyelitis optica spectrum disorder associated with myasthenia gravis and a review of the literature.
Hematopoietic mobilization: Potential biomarker of response to natalizumab in multiple sclerosis.
Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude.
Consensus guidelines for the diagnosis and treatment of multiple sclerosis.
Fatigue in multiple sclerosis: relationship with disease duration, physical disability, disease pattern, age and sex.
Atomic view of a toxic amyloid small oligomer.
A novel immunomodulator, FTY-720 reverses existing cardiac hypertrophy and fibrosis from pressure overload by targeting NFAT (nuclear factor of activated T-cells) signaling and periostin.
Glatiramer acetate for treatment of relapsing-remitting multiple sclerosis.
Pharmacological effects of CS-0777, a selective sphingosine 1-phosphate receptor-1 modulator: Results from a 12-week, open-label pilot study in multiple sclerosis patients.
The therapeutic potential of cannabis and cannabinoids.
Erratum.
Depression in multiple sclerosis: A long-term longitudinal study.
Myelination at a glance.
Pages
« first
‹ previous
…
264
265
266
267
268
269
270
271
272
…
next ›
last »